NanoString Technologies Inc (NASDAQ:NSTG) major shareholder Lifesciences Ii L.P. Clarus sold 2,000,000 shares of the business’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $21.62, for a total transaction of $43,240,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Shares of NSTG traded down $0.79 during mid-day trading on Friday, hitting $23.44. The company’s stock had a trading volume of 346,596 shares, compared to its average volume of 506,007. NanoString Technologies Inc has a 52-week low of $6.30 and a 52-week high of $31.14. The stock has a market capitalization of $742.50 million, a PE ratio of -8.42 and a beta of 1.32. The company has a debt-to-equity ratio of 1.58, a quick ratio of 2.75 and a current ratio of 3.05.
NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings results on Thursday, March 7th. The biotechnology company reported ($0.68) earnings per share for the quarter, missing the consensus estimate of ($0.50) by ($0.18). NanoString Technologies had a negative return on equity of 252.59% and a negative net margin of 72.52%. The business had revenue of $30.03 million during the quarter. Equities research analysts forecast that NanoString Technologies Inc will post -2.43 EPS for the current year.
Several equities research analysts have recently weighed in on NSTG shares. BidaskClub raised shares of NanoString Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, November 27th. ValuEngine cut shares of NanoString Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 18th. Zacks Investment Research cut shares of NanoString Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, March 12th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a $35.00 price target on shares of NanoString Technologies in a research report on Friday, March 8th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $22.80.
ILLEGAL ACTIVITY WARNING: “Insider Selling: NanoString Technologies Inc (NSTG) Major Shareholder Sells 2,000,000 Shares of Stock” was published by WKRB News and is owned by of WKRB News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.wkrb13.com/2019/03/22/insider-selling-nanostring-technologies-inc-nstg-major-shareholder-sells-2000000-shares-of-stock.html.
NanoString Technologies Company Profile
NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
Read More: What is the strike price in options trading?
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.